Pericardial effusion with tamponade physiology induced by nivolumab-Reference-Cited by-同舟云学术

Pericardial effusion with tamponade physiology induced by nivolumab

Published:2016-11 Issue: Volume:222 Page:613-614
ISSN:0167-5273
Container-title:International Journal of Cardiology
language:en
Short-container-title:International Journal of Cardiology

Author:

Nesfeder Jennifer,Elsensohn Ashley N.,Thind Munveer,Lennon James,Domsky Steven

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference9 articles.

2. Nivolumab in previously untreated melanoma without BRAF mutation;Robert;N. Engl. J. Med.,2015

3. Late onset ipilimumab-induced pericarditis and pericardial effusion: a rare but life threatening complication;Yun;Case Rep. Oncol. Med.,2015

4. Late-onset pericardial tamponade, bilateral pleural effusions and recurrent immune monoarthritis induced by ipilimumab use for metastatic melanoma;Dasanu;J. Oncol. Pharm. Pract.,2016

5. Constrictive pericarditis in the modern era : evolving clinical spectrum and impact on outcome after pericardiectomy;Ling;Circulation,1999

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recurrent Pericardial Effusion in a Patient With Delayed Progression of Melanoma Treated With Immune Checkpoint Inhibitors;Cureus;2023-10-26

2. Late-Onset Hemorrhagic Pericardial Effusion and Cardiac Tamponade Associated With Immune Checkpoint Inhibitors: Case Report and Literature Review;Cureus;2023-08-02

3. Cardiovascular Toxicity Associated With Immune Checkpoint Inhibitor Therapy: A Comprehensive Review;Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine;2023-06-26

4. Pericarditis. Clinical Guidelines 2022;Russian Journal of Cardiology;2023-03-11